Randomised controlled trial of active case management to link hepatitis C notifications to treatment in Tasmania, Australia: a study protocol

INTRODUCTION: By subsidising access to direct acting antivirals (DAAs) for all people living with hepatitis C (HCV) in 2016, Australia is positioned to eliminate HCV as a public health threat. However, uptake of DAAs has declined over recent years and new initiatives are needed to engage people livi...

Descripción completa

Detalles Bibliográficos
Autores principales: Marukutira, Tafireyi, Moore, Karen P, Hellard, Margaret, Richmond, Jacqui, Turner, Kate, Pedrana, A E, Melody, Shannon, Johnston, Fay H, Owen, Louise, Van Den Boom, Wijnand, Scott, N, Thompson, Alexander, Iser, David, Spelman, Tim, Veitch, Mark, Stoové, Mark A, Doyle, Joseph
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Public Health
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8961121/
https://www.ncbi.nlm.nih.gov/pubmed/35338062
http://dx.doi.org/10.1136/bmjopen-2021-056120

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8961121/
https://www.ncbi.nlm.nih.gov/pubmed/35338062
http://dx.doi.org/10.1136/bmjopen-2021-056120

Ejemplares similares